Tatiana Da Ros, Carlo Alfieri, Piergiorgio Messa, Silvia Armelloni, Francesco Cellesi, Deborah Mattinzoli, Jose M. González-Domínguez, Belén Ballesteros, Adrian Ostric, Masami Ikehata, Akcan Istif, Caroline Hadad, Ministerio de Economía, Industria y Competitividad (España), European Commission, Ministero dell'Istruzione, dell'Università e della Ricerca, Università degli studi di Trieste, Ministerio de Economía y Competitividad (España), Agencia Estatal de Investigación (España), Ministerio de Ciencia, Innovación y Universidades (España), González Domínguez, José Miguel [0000-0002-0701-7695], Armelloni, Silvia [0000-0001-6431-2642], Ikehata, Masami [0000-0001-9835-9991], Istif, Akcan [0000-0001-6245-8998], Cellesi, Francesco [0000-0001-6106-9317], Alfieri, Carlo Maria [0000-0003-3860-5219], Messa, Piergiorgio [0000-0002-1512-559X], Ballesteros, Belén [0000-0002-1958-8911], Da Ros, Tatiana [0000-0003-1932-1560], Hadad, C., Gonzalez-Dominguez, J. M., Armelloni, S., Mattinzoli, D., Ikehata, M., Istif, A., Ostric, A., Cellesi, F., Alfieri, C. M., Messa, P., Ballesteros, B., Da Ros, T., González Domínguez, José Miguel, Armelloni, Silvia, Ikehata, Masami, Istif, Akcan, Cellesi, Francesco, Alfieri, Carlo Maria, Messa, Piergiorgio, Ballesteros, Belén, and Da Ros, Tatiana
7 figures.-- Supplementary material available on line (6 figures).-- This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder., Carbon nanomaterials offer excellent prospects as therapeutic agents, and among them, graphene quantum dots (GQDs) have gained considerable interest thanks to their aqueous solubility and intrinsic fluorescence, which enable their possible use in theranostic approaches, if their biocompatibility and favorable pharmacokinetic are confirmed. We prepared ultra-small GQDs using an alternative, reproducible, top-down synthesis starting from graphene oxide with a nearly 100% conversion. The materials were tested to assess their safety, demonstrating good biocompatibility and ability in passing the ultrafiltration barrier using an in vitro model. This leads to renal excretion without affecting the kidneys. Moreover, we studied the GQDs in vivo biodistribution confirming their efficient renal clearance, and we demonstrated that the internalization mechanism into podocytes is caveolae-mediated. Therefore, considering the reported characteristics, it appears possible to vehiculate compounds to kidneys by means of GQDs, overcoming problems related to lysosomal degradation., J. M. G.-D. acknowledges Spanish Ministry of Science, Innovation and Universities for his Juan de la Cierva Incorporación research contract (No. IJCI-2016-27789). This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under the Marie Skłodowska-Curie Grant Agreement No. 734834 (INFUSION) and No. 734381 (CARBO-IMmap), and from MIUR. ICN2 is supported by the Severo Ochoa program from Spanish MINECO (No. SEV-2017-0706)., Funding note : Open Access funding provided by Università degli Studi di Trieste within the CRUICARE Agreement.